Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Pfizer's Lyme disease vaccine shows 70% efficacy despite trial shortfall
Pfizer $PFE +1.19% plans to seek regulatory approval for a Lyme disease vaccine that reduced infections by more than 70% in a late-stage trial but missed its primary statistical goal, the company said Monday.
The vaccine, co-developed with French drugmaker Valneva, blocked 73.2% of confirmed infections versus placebo — a figure measured beginning four weeks after the final injection. A lower-than-projected number of infections caused the trial to miss its primary requirement — that even a pessimistic statistical reading show at least 20% protection. That floor came in at 15.8% in the initial analysis, according to NBC News. The second pre-specified analysis cleared that bar, recording 74.8% efficacy.
Related Content
Walmart is bringing digital price tags to every U.S. store by end of 2026
LaGuardia is temporarily closed after Air Canada Express jet collides with fire truck
“Lyme disease can cause potentially serious consequences — where individuals and families face symptoms that can disrupt daily life, work, and long-term health — and there is currently no vaccine available,” Annaliesa Anderson, chief vaccines officer at Pfizer, said in a statement.
Approval would make it the sole human Lyme disease vaccine on the market. LYMErix, a predecessor vaccine that had demonstrated 76% efficacy at its 1998 approval, was pulled from the market in 2002 after adverse-event reports fueled public concern and cratered demand, according to The Washington Post. A 2006 editorial in the journal Epidemiology and Infection attributed the earlier vaccine’s failure largely to public perception of risk, shaped by negative press coverage, rather than evidence of harm found by regulators.
Lyme disease is caused by bacteria spread by bites from infected blacklegged ticks. Early symptoms usually include fever, fatigue, headache, and a bulls-eye rash at the bite. If not treated, the disease can lead to heart inflammation, joint damage, and nerve problems. The CDC estimates about 476,000 Americans are diagnosed and treated each year. Pfizer and Valneva estimate about 132,000 cases annually in Europe.
The study included roughly 9,400 participants, from children as young as 5 to adults. That was down from an original pool of about 18,000 after the companies removed roughly half their participants in 2023 following quality problems at an outside clinical site operator, according to CNBC. The trial data have not been independently reviewed or published in a scientific journal. No safety concerns were observed, the companies said.
The dosing schedule spans two years: three injections in the first year — spaced two months apart for the first two, with the third given between five and nine months after the second — followed by a booster in the second year. Valneva has projected a commercial launch in the latter half of 2027, assuming regulators clear the shot.
Valneva stock fell more than a third in premarket trading on the announcement. Pfizer stock was little changed.
📬 Sign up for the Daily Brief
Our free, fast and fun briefing on the global economy, delivered every weekday morning.
Sign me up
10 Stocks in the Defense Spending BoomSeeking Alpha |
SponsoredSponsored
Read More
Undo
Not a typical dating platformGoldenAgeSouls |
SponsoredSponsored
Read More
Undo
Inflation Risk Is Back, And Oil Is The TriggerSeeking Alpha |
SponsoredSponsored
Read More
Undo
Your Next “Wow” May Be Closer Than You Think.Funchatt |
SponsoredSponsored
Click Here
Undo
Tokyoの少年が住む8平方メートルの部屋。その中をご覧ください!FitDib |
SponsoredSponsored
Undo
一生涯続く、確かな保障!全国労働者共済生活協同組合連合会 |
SponsoredSponsored
Undo
Tokyoの少年、5畳の家に住んでる!さっそく中身を見てみよう!FitDib |
SponsoredSponsored
Undo
入院・手術・通院、まるごと安心全国労働者共済生活協同組合連合会 |
SponsoredSponsored
Undo
育児のスキマで「声優になれる」顔出し不要のYouTube声優とは?スクリプトルコンサルティング |
SponsoredSponsored
Undo
「食べないで!」心臓専門医が警告する最悪の食品12選NewSphere |
SponsoredSponsored
Undo
「30代からでも声優になれる」顔出し不要の在宅声優とは?スクリプトルコンサルティング |
SponsoredSponsored
Undo
Why thousands of women are switching to this braReview Beauty |
SponsoredSponsored
Undo
Do You Remember Her? Take A Deep Breath Before Looking At Her Now.Unfaility.com |
SponsoredSponsored
Undo
Elizabeth Holmes’ prison sentence keeps getting shorterQuartz
Undo
10 travel destinations that give you the most for your moneyQuartz
Undo
What Is the Cost of Living in a Dubai Apartment in 2026?Apartments in Dubai | Search Ads |
SponsoredSponsored
Learn More
Undo
30 Photos That Really Make You ThinkCelebsland.com |
SponsoredSponsored
Undo
「世界ソフトパワーランキング」1位は"ずば抜けている"あの国!NewSphere |
SponsoredSponsored
Undo
Jenny McCarthy Embraces Her Shape in Stunning New Photos.Vetob |
SponsoredSponsored
Undo
This anti-sagging bra is so comfy, women won’t take it off — even at night !Review Beauty |
SponsoredSponsored
Undo
MOST POPULAR
The woman who sued Donald Trump alleging child rape has called off her press conferenceQuartz
Undo
MOST POPULAR
Ex-Trump lawyer Michael Cohen says he unwittingly sent AI-generated fake legal cases to his attorneyQuartz
Undo
David Bowie’s daughter is one of the most beautiful women on the planet.Tipgalore |
SponsoredSponsored
Undo
Sandra Bullock, 61, Takes off Her Makeup and Leaves Us SpeechlessVetob |
SponsoredSponsored
Undo
Monica Lewinsky’s House Makes Alcatraz Looks Like A ParadiseEzzin.com |
SponsoredSponsored
Undo